BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 7529997)

  • 1. Stopped-flow fluorescence kinetics of bovine alpha 2-antiplasmin inhibition of bovine midiplasmin.
    Christensen S; Sottrup-Jensen L; Christensen U
    Biochem J; 1995 Jan; 305 ( Pt 1)(Pt 1):97-102. PubMed ID: 7529997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reaction of human alpha2-antiplasmin and plasmin stopped-flow fluorescence kinetics.
    Christensen U; Bangert K; Thorsen S
    FEBS Lett; 1996 May; 387(1):58-62. PubMed ID: 8654567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of kringles derived from human plasminogen on fibrinolysis in vitro.
    Sugiyama N; Iwamoto M; Abiko Y
    Thromb Res; 1987 Aug; 47(4):459-68. PubMed ID: 2821651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Features of the interaction between alpha2-antiplasmin and plasminogen/plasmin].
    Hrynenko TV; Iusova OI; Zadorozhna MB; Makohonenko IeM
    Ukr Biokhim Zh (1999); 2002; 74(6):83-90. PubMed ID: 12924019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of fibrinogen and its cleavage products on the kinetics of plasminogen activation by urokinase and subsequent plasmin activity.
    Lucas MA; Straight DL; Fretto LJ; McKee PA
    J Biol Chem; 1983 Oct; 258(20):12171-7. PubMed ID: 6226655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional hierarchy of plasminogen kringles 1 and 4 in fibrinolysis and plasmin-induced cell detachment and apoptosis.
    Ho-Tin-Noé B; Rojas G; Vranckx R; Lijnen HR; Anglés-Cano E
    FEBS J; 2005 Jul; 272(13):3387-400. PubMed ID: 15978044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
    Suenson E; Thorsen S
    Biochem J; 1981 Sep; 197(3):619-28. PubMed ID: 6459779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein (a) promotes plasmin inhibition by alpha 2-antiplasmin.
    Edelberg JM; Pizzo SV
    Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):79-84. PubMed ID: 1381585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural/functional characterization of the alpha 2-plasmin inhibitor C-terminal peptide.
    Frank PS; Douglas JT; Locher M; Llinás M; Schaller J
    Biochemistry; 2003 Feb; 42(4):1078-85. PubMed ID: 12549929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation by alpha 2-antiplasmin and fibrin of the activation of plasminogen with recombinant staphylokinase in plasma.
    Silence K; Collen D; Lijnen HR
    Blood; 1993 Aug; 82(4):1175-83. PubMed ID: 7688990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino-terminal fragment of urokinase-type plasminogen activator inhibits its plasminogen activation.
    Sun Z; Zhang PX; Wang P; Gurewich V; Shen HY; Liu JN
    Thromb Res; 2002 Apr; 106(2):105-11. PubMed ID: 12182908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the kinetics of the reaction between human antiplasmin and a low-molecular-weight form of plasmin.
    Wiman B; Boman L; Collen D
    Eur J Biochem; 1978 Jun; 87(1):143-6. PubMed ID: 149657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kringles of substrate plasminogen provide a 'catalytic switch' in plasminogen to plasmin turnover by Streptokinase.
    Sharma V; Kumar S; Sahni G
    Biochem J; 2020 Mar; 477(5):953-970. PubMed ID: 32069359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-molecular-mass and low-molecular-mass kininogens block plasmin-induced platelet aggregation by forming a complex with kringle 5 of plasminogen/plasmin.
    Selim TE; Ghoneim HR; Uknis AB; Colman RW; DeLa Cadena RA
    Eur J Biochem; 1997 Dec; 250(2):532-8. PubMed ID: 9428707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of plasmin binding and urokinase activation of plasminogen bound to the Heymann nephritis autoantigen, gp330.
    Kanalas JJ
    Arch Biochem Biophys; 1992 Dec; 299(2):255-60. PubMed ID: 1280065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of molecular forms of plasminogen and plasmin-inhibitor complexes in urokinase-activated human plasma.
    Müllertz S; Thorsen S; Sottrup-Jensen L
    Biochem J; 1984 Oct; 223(1):169-77. PubMed ID: 6208893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between staphylokinase, plasmin(ogen), and alpha 2-antiplasmin. Recycling of staphylokinase after neutralization of the plasmin-staphylokinase complex by alpha 2-antiplasmin.
    Silence K; Collen D; Lijnen HR
    J Biol Chem; 1993 May; 268(13):9811-6. PubMed ID: 7683664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of plasmin inhibition in the presence of a synthetic tripeptide substrate. The reaction with pancreatic trypsin inhibitor and two forms of alpha 2-plasmin inhibitor.
    Petersen LC; Clemmensen I
    Biochem J; 1981 Oct; 199(1):121-7. PubMed ID: 6175313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decoy plasminogen receptor containing a selective Kunitz-inhibitory domain.
    Kumar Y; Vadivel K; Schmidt AE; Ogueli GI; Ponnuraj SM; Rannulu N; Loo JA; Bajaj MS; Bajaj SP
    Biochemistry; 2014 Jan; 53(3):505-17. PubMed ID: 24383758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of streptokinase on the interaction of alpha-2-antiplasmin with different sites of plasmin molecule].
    Iusova EI; Grinenko TV; Volkov GL
    Ukr Biokhim Zh (1999); 2004; 76(2):98-106. PubMed ID: 15915719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.